Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqGS - Nasdaq Real Time Price USD

Absci Corporation (ABSI)

Compare
2.2700
-0.0500
(-2.16%)
At close: April 8 at 4:00:02 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
4,534
4,534
5,718
5,747
4,782
Operating Expense
113,422
113,422
99,898
112,497
80,020
Operating Income
-108,888
-108,888
-94,180
-106,750
-75,238
Net Non Operating Interest Income Expense
-565
-565
-1,010
-972
-3,432
Other Income Expense
6,417
6,417
-15,276
2,357
-31,189
Pretax Income
-103,036
-103,036
-110,466
-105,365
-109,859
Tax Provision
70
70
100
-461
-8,899
Net Income Common Stockholders
-103,106
-103,106
-110,566
-104,904
-103,244
Diluted NI Available to Com Stockholders
-103,106
-103,106
-110,566
-104,904
-103,244
Basic EPS
-0.94
--
-1.20
-1.15
-2.08
Diluted EPS
-0.94
--
-1.20
-1.15
-2.08
Basic Average Shares
110,239.8700
--
92,028.0160
90,845.6290
49,685.1940
Diluted Average Shares
110,239.8700
--
92,028.0160
90,845.6290
49,685.1940
Total Operating Income as Reported
-108,888
-108,888
-115,515
-106,750
-75,238
Total Expenses
113,422
113,422
99,898
112,497
80,020
Net Income from Continuing & Discontinued Operation
-103,106
-103,106
-110,566
-104,904
-100,960
Normalized Income
-103,106
-103,106
-93,711.3500
-104,904
-100,960
Interest Expense
565
565
1,010
972
3,432
Net Interest Income
-565
-565
-1,010
-972
-3,432
EBIT
-102,471
-102,471
-109,456
-104,393
-106,427
EBITDA
-89,082
-89,082
-95,457
-91,293
-99,773
Reconciled Depreciation
13,389
13,389
13,999
13,100
6,654
Net Income from Continuing Operation Net Minority Interest
-103,106
-103,106
-110,566
-104,904
-100,960
Total Unusual Items Excluding Goodwill
--
--
-21,335
--
--
Total Unusual Items
--
--
-21,335
--
--
Normalized EBITDA
-89,082
-89,082
-74,122
-91,293
-99,773
Tax Rate for Calcs
0.0002
0.0002
0.0002
0
0.0001
Tax Effect of Unusual Items
--
--
-4,480.3500
--
--
12/31/2021 - 7/22/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

RXRX Recursion Pharmaceuticals, Inc.
3.9700
-5.48%
 
PRME Prime Medicine, Inc.
1.1500
-11.54%
 
BEAM Beam Therapeutics Inc.
14.54
-4.97%
 
ABCL AbCellera Biologics Inc.
1.9300
-5.85%
 
SANA Sana Biotechnology, Inc.
1.3400
-12.42%
 
NTLA Intellia Therapeutics, Inc.
6.28
-3.98%
 
RLAY Relay Therapeutics, Inc.
2.0000
-2.44%
 
DNA Ginkgo Bioworks Holdings, Inc.
5.76
-10.14%
 
FATE Fate Therapeutics, Inc.
0.9058
-0.40%
 
IOVA Iovance Biotherapeutics, Inc.
2.8500
-5.94%